Evidence map›Paper›PMID 29088770›Full record

ArticleOncotarget2017

Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer.

Hongchao Zhen, Liuting Yang, Li Li, Junxian Yu, Lei Zhao, Yingying Li, Qin Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongchao ZhenDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Liuting YangDepartment of Biochemistry and Molecular Biology, Basic Medical College, Shanxi Medical University, Taiyuan, 030001, China.
Li LiDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Junxian YuDepartment of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Lei ZhaoDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Yingying LiDepartment of Pathology and Pathophysiology, Basic Medical College, Capital Medical University, Beijing, 100069, China.
Qin LiDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular subtypes and Nottingham Prognostic Index (NPI) are both prognostic models for breast cancer patients. We evaluated the association between molecular subtypes and NPI in 1042 breast cancer patients. The molecular subtypes indicating poorer prognosis were positively correlated to higher NPI (

Indexed as

breast cancercorrelation analysismolecular subtypesNottingham Prognostic Indexprognosis

Identifiers

PMID29088770
PMCPMC5650325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.